Tesamorelin/Ipamorelin Blend
Tesamorelin and Ipamorelin Blend
Description
A potent growth hormone secretagogue combination. Tesamorelin provides sustained GHRH stimulation while Ipamorelin adds selective GH pulsatility for optimal fat loss and muscle building.
Overview
Tesamorelin + Ipamorelin is a peptide blend used to support natural GH pulsatility with a metabolic focus. It is studied for reduction of visceral adipose tissue and support of lean mass.
Mechanism of Action
Tesamorelin is a GHRH analog that drives endogenous GH release with strong effects on metabolism and visceral fat. Ipamorelin is a selective GHRP that adds a clean pulse of GH secretion. Combined, they support natural pulsatile GH release.
Benefits
- •Enhanced fat loss
- •Muscle building
- •GH optimization
- •Body recomposition
Dosing Notes
Typically self-injected subcutaneously at night to align with natural GH pulses. Cycle on ~3 months and off ~4 weeks is commonly described.
Reported Side Effects
- •Injection-site reactions
- •Mild fluid retention or bloating
- •Joint stiffness or arthralgia
- •Myalgia
- •Peripheral edema
- •Vivid dreams
- •Increased appetite
Safety Notes
Not FDA-approved as a compounded blend. Can raise IGF-1; HbA1c should be checked before re-cycling. Rare reported risks include glucose intolerance, hypersensitivity, and theoretical tumor-growth stimulation.
Scientific References
Related Weight Loss Peptides
Tesofensine
Tesofensine
A serotonin-norepinephrine-dopamine reuptake inhibitor originally studied as an anti-obesity agent. Promotes weight loss through appetite suppression.
0.25-1 mgAOD-9604
Anti-Obesity Drug 9604
A synthetic peptide analog of natural AOD-9604 fragment that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.
300 mcg5-Amino-1MQ
5-Amino-1-Methylquinolinium
A small molecule that inhibits NNMT enzyme, boosting NAD+ levels and cellular energy. Supports fat loss and metabolic function.
1 mgIpamorelin/CJC-1295 No DAC
Ipamorelin and CJC-1295 without DAC Blend
A powerful synergistic combination of growth hormone secretagogues. Ipamorelin provides selective GH release while CJC-1295 extends GH pulse duration for enhanced fat loss and recovery.
250 mcg each